CDKN2A and meningioma: While meningiomas with CDKN2A deletion bypass the G1/S checkpoint due to constitutive activation of E2F, those with an intact CDKN2A gene must evade the G1/S checkpoint and p53-mediated apoptotic pathways before the cell cycle can be allowed to progress.